Pathological Complete Response in Locally Advanced Breast Cancer after Neoadjuvant Chemotherapy: Survival Outcome and Its Relevance as a Surrogate End Point
Background Pathological complete response (pCR) to neoadjuvant chemotherapy has emerged as a reliable surrogate marker for improved survival in breast cancer (BC), but its role as a surrogate end point is still controversial. Aims and Objectives The aim of the study is to investigate the clinical c...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2020-07-01
|
| Col·lecció: | South Asian Journal of Cancer |
| Matèries: | |
| Accés en línia: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1721238 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|